Literature DB >> 6290600

Transmission of hepatitis A virus among recently captured Panamanian owl monkeys.

S M Lemon, J W LeDuc, L N Binn, A Escajadillo, K G Ishak.   

Abstract

The presence of antibody to hepatitis A virus (anti-HAV) in 60% of procured owl monkeys (Aotus trivirgatus) held within the United States prompted a study of recently captured A trivirgatus in Panama. Only 2 of 145 newly captured monkeys, but all of 35 A trivirgatus held within a colony for over 100 days, were found to have anti-HAV. Of 41 sero-negative, newly captured monkeys followed prospectively, 25 became infected with hepatitis A virus (HAV) as evidenced by seroconversion or demonstration of virus in the liver at death. Only one monkey that survived over 60 days within the colony was not infected. HAV was identified in the feces of most infected monkeys prior to the development of antibody and was antigenically indistinguishable from human HAV in cross-blocking radioimmunoassays. This colony-centered epizootic provides strong evidence that A trivirgatus is susceptible to HAV and should be investigated further as a potential model of human hepatitis A.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290600     DOI: 10.1002/jmv.1890100105

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

1.  Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes.

Authors:  C A Blank; D A Anderson; M Beard; S M Lemon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein.

Authors:  Mauro Costa-Mattioli; Juan Cristina; Héctor Romero; Raoul Perez-Bercof; Didier Casane; Rodney Colina; Laura Garcia; Ines Vega; Graciela Glikman; Victor Romanowsky; Alejandro Castello; Elisabeth Nicand; Michelle Gassin; Sylviane Billaudel; Virginie Ferré
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.

Authors:  S M Lemon; P C Murphy; P A Shields; L H Ping; S M Feinstone; T Cromeans; R W Jansen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Protease digestion of hepatitis A virus: disparate effects on capsid proteins, antigenicity, and infectivity.

Authors:  S M Lemon; E Amphlett; D Sangar
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  High prevalence of antibodies against hepatitis A virus among captive nonhuman primates.

Authors:  Pattaratida Sa-nguanmoo; Nutchanart Thawornsuk; Pornpimol Rianthavorn; Angkana Sommanustweechai; Parntep Ratanakorn; Yong Poovorawan
Journal:  Primates       Date:  2009-10-10       Impact factor: 2.163

6.  Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens.

Authors:  R W Jansen; J E Newbold; S M Lemon
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.

Authors:  L H Ping; R W Jansen; J T Stapleton; J I Cohen; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures.

Authors:  L N Binn; S M Lemon; R H Marchwicki; R R Redfield; N L Gates; W H Bancroft
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

9.  Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.

Authors:  E A Brown; R W Jansen; S M Lemon
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Pathology of hepatitis A infection in the owl monkey (Aotus trivirgatus).

Authors:  C M Keenan; S M Lemon; J W LeDuc; G A McNamee; L N Binn
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.